Oct 14 (Reuters)-
Chordia Therapeutics Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Aug 31, 2025 Aug 31, 2024 Aug 31, 2026 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Operating loss 1.79 loss 1.80 loss 2.01
Recurring loss 1.77 loss 1.82 loss 1.96
Net loss 1.79 loss 1.83 loss 1.96
EPS loss 26.03 yen loss 31.11 yen loss 28.41 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Chordia Therapeutics Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=190A.T